Lorne E. Albrecht, MD, FRCPC


Enverus Medical Research

13737 96 Avenue, Suite 603
Surrey, British Columbia, Canada
V3V 0C6

Specialty: Dermatology

Dr. Lorne Albrecht, Dermatologist

Research Interests: Acne, Actinic Keratoses, Atopic Dermatitis, Hyperhidrosis, Onychomycosis, Psoriasis, Psoriatic Arthritis, Rosacea, Seborrhoeic Dermatitis


Dr. Lorne Albrecht is a board certified dermatologist, who has been practicing dermatology in Surrey, British Columbia since 1997. He has a well-established practice in Guildford for clinical and cosmetic dermatology and was one of the first providers of Botox in British Columbia.

An invited lecturer on many dermatology topics, Dr. Albrecht can be found speaking to other physicians nationally and internationally. Locally Dr. Albrecht lectures at the University of British Columbia where he is a Clinical Assistant Professor.

Dr. Albrecht has been conducting clinical trials since 2002. As the Principal Investigator for over 35 clinical trials in dermatology, Dr. Albrecht has experience in Phase II-IV clinical research studies for indications including psoriasis, psoriatic arthritis, atopic dermatitis, onychomycosis, and acne.


Click to view Dr. Lorne Albrecht's Publications

Papp K, Albrecht L, Barber K, Bourcier M, Dion P-L, Freiman A, Gooderham M, Guenther L, Gulliver W, Hong C, Lynde C, Poulin Y, Siddha S, Toole J, Toth D, Vender R, Wasel N, Wiseman M. An open letter to Health Canada. J Cutan Med Surg 2017; 21(3): 195-6. doi: 10.1177/1203475417704642

Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Two Phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 2016 Dec 15; 375(24): 2335-48. Epub 2016 Sep 30. PMID: 27690741

Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis. N Engl J Med 2016 Jul 28; 375(4): 345-56. Epub 2016 Jun 8. PMID: 27299809 / doi: 10.1056/NEJMoa1512711

Papp KA, Menter MA, Abe M, Elewski B, Feldman SR, Gottlieb AB, Langley R, Luger T, Thaci D, Buonanno M, Gupta P, Proulx J, Lan S, Wolk R, OPT Pivotal 1 and OPT Pivotal 2 investigators. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials. Br J Dermatol 2015 Oct; 173(4): 949-61. PMID: 26149717 / doi: 10.1111/bjd.14018

Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K, UNCOVER-2 and UNCOVER-3 investigators. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 2015 Aug 8; 386(9993): 541-51. Epub 2015 Jun 10. PMID: 26072109 / doi: 10.1016/S0140-6736(15)60125-8

Tan J, Humphrey S, Vender R, Barankin B, Gooderham M, Kerrouche N, Audibert F, Lynde C, POWER study group. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin. Br J Dermatol 2014 Dec; 171(6): 1508-16. Epub 2014 Oct 28. PMID: 24934963 / doi: 10.1111/bjd.13191

Stein Gold L, Kircik L, Fowler J, Jackson JM, Tan J, Draelos Z, Fleischer A, Appell M, Steinhoff M, Lynde C, Sugarman J, Liu H, Jacovella J, Ivermectin Phase 3 Study Group. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials. J Drugs Dermatol 2014 Nov; 13(11): 1380-6. PMID: 25607706

Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C, ERASURE Study Group, FIXTURE Study Group. Secukinumab in plaque psoriasis--results of two phase 3 trials. N Engl J Med 2014 Jul 24; 371(4): 326-38. Epub 2014 Jul 9. PMID: 25007392 / doi: 10.1056/NEJMoa1314258

Levy AR, Davie AM, Brazier NC, Jivraj F, Albrecht LE, Gratton D, Lynde CW. Economic burden of moderate to severe plaque psoriasis in Canada. Int J Dermatol 2012 Dec; 51(12): 1432-40. PMID: 23171010 /  doi: 10.1111/j.1365-4632.2011.05359.x

Albrecht L, Bourcier M, Ashkenas J, Papp K, Canadian Psoriasis Guidelines Committee. Topical psoriasis therapy in the age of biologics: evidence-based treatment recommendations. J Cutan Med Surg 2011 Nov-Dec; 15(6): 309-21. PMID: 22202506

Papp K, Gulliver W, Lynde C, Poulin Y, Ashkenas J, Canadian Psoriasis Guidelines Committee. Canadian guidelines for the management of plaque psoriasis: overview. J Cutan Med Surg 2011 Jul-Aug; 15(4): 210-9. PMID: 21781627

Eichenfield LF, Jarratt M, Schlessinger J, Kempers S, Manna V, Hwa J, Liu Y, Graeber M, Adapalene Lotion Study Group. Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies. J Drugs Dermatol 2010 Jun; 9(6): 639-646. PMID: 20645525

Gollnick HP, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, Gore B, Liu Y, Graeber M, Adapalene-BPO Study Group.  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.  Br J Dermatol 2009 Nov; 161(5):1180-1189.  Epub 2009 May 21.  PMID: 19466959

Albrecht LE, Tron V, Rivers JK. Cutaneous endometriosis. Int J Dermatol 1995 Apr; 34(4): 261-262. PMID: 7790141

Rivers JK, Albrecht LE, Tron VC.  Chapter: “Epithelial Neoplasms”. In: Dover JS (Ed.), Cutaneous Medicine and Surgery: Self-Assessment and Review. W.B. Saunders: Philadelphia, 1994.

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.